The Journal of international medical research · 2021
Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.
СтатьяМетаанализСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Adane Tiruneh, Getawa Solomon
Аннотация
BACKGROUND: Screening for cytomegalovirus (CMV)-specific antibodies is not routine in some settings. Thus, transfusion of blood products poses risks for susceptible individuals.
OBJECTIVES: To investigate the global pooled CMV seroprevalence among volunteer blood donors.
METHODS: This systematic review and meta-analysis was performed according to PRISMA guidelines. The databases searched included Embase, Google Scholar, Medline, PubMed, Web of Science, and Cochrane Library. Data were extracted independently and analyzed using STATA version 11.
RESULTS: The global seroprevalence of CMV IgG, CMV IgM, and both CMV IgM and IgG was 83.16% (95% confidence interval [CI]: 78.55-87.77%, I2 = 99.5%), 13.77% (95% CI: 11.59-15.95%, I2 = 98.8%), and 23.78% (95% CI: 10.50-37.06%, I2 = 98.7), respectively.
CONCLUSION: The global seroprevalence of CMV was high among blood donors. Therefore, regular CMV screening should be conducted to identify CMV-seronegative blood donors.
OBJECTIVES: To investigate the global pooled CMV seroprevalence among volunteer blood donors.
METHODS: This systematic review and meta-analysis was performed according to PRISMA guidelines. The databases searched included Embase, Google Scholar, Medline, PubMed, Web of Science, and Cochrane Library. Data were extracted independently and analyzed using STATA version 11.
RESULTS: The global seroprevalence of CMV IgG, CMV IgM, and both CMV IgM and IgG was 83.16% (95% confidence interval [CI]: 78.55-87.77%, I2 = 99.5%), 13.77% (95% CI: 11.59-15.95%, I2 = 98.8%), and 23.78% (95% CI: 10.50-37.06%, I2 = 98.7), respectively.
CONCLUSION: The global seroprevalence of CMV was high among blood donors. Therefore, regular CMV screening should be conducted to identify CMV-seronegative blood donors.